Aptus Pharma Ltd (APTM)

Currency in INR
92.30
+2.51(+2.80%)
Closed·
APTM Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Trading near 52-week High
APTM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
92.0094.27
52 wk Range
80.8094.27
Key Statistics
Bid/Ask
91.00 / 94.00
Prev. Close
89.79
Open
93
Day's Range
92-94.27
52 wk Range
80.8-94.27
Volume
56K
Average Volume (3m)
155.78K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APTM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Aptus Pharma Ltd Company Profile

Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division which includes marketing of chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products; and Aptus Global, export division engages in exploring and developing opportunities in overseas markets, semi-regulated and emerging countries. It also offers anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. Its products are available in balms, capsules, drops, gels, injections, lotions, ointments, powders, sachets, softgels, solutions, suspensions, syrups, tablets, and vials. It distributes the products through clearing and forwarding agents. Aptus Pharma Limited was incorporated in 2010 and is headquartered in Rajkot, India.

0
Market
India

Compare APTM to Peers and Sector

Metrics to compare
APTM
Peers
Sector
Relationship
P/E Ratio
19.9x39.8x−0.7x
PEG Ratio
1.790.210.00
Price/Book
-3.0x2.6x
Price / LTM Sales
2.5x3.8x3.4x
Upside (Analyst Target)
-4.1%37.9%
Fair Value Upside
Unlock−10.6%5.2%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

APTM Income Statement

FAQ

What Stock Exchange Does Aptus Pharma Trade On?

Aptus Pharma is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Aptus Pharma?

The stock symbol for Aptus Pharma is "APTM."

What Is the Aptus Pharma Market Cap?

As of today, Aptus Pharma market cap is 615.96M.

What Is Aptus Pharma's Earnings Per Share (TTM)?

The Aptus Pharma EPS (TTM) is 6.37.

From a Technical Analysis Perspective, Is APTM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Aptus Pharma Stock Split?

Aptus Pharma has split 0 times.

How Many Employees Does Aptus Pharma Have?

Aptus Pharma has 0 employees.

What is the current trading status of Aptus Pharma (APTM)?

As of 13 Oct 2025, Aptus Pharma (APTM) is trading at a price of 92.30, with a previous close of 89.79. The stock has fluctuated within a day range of 92.00 to 94.27, while its 52-week range spans from 80.80 to 94.27.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.